Indoco Remedies Balance Sheet Health
Financial Health criteria checks 3/6
Indoco Remedies has a total shareholder equity of ₹10.9B and total debt of ₹8.2B, which brings its debt-to-equity ratio to 75.2%. Its total assets and total liabilities are ₹23.9B and ₹13.0B respectively. Indoco Remedies's EBIT is ₹938.1M making its interest coverage ratio 1.9. It has cash and short-term investments of ₹417.3M.
Key information
75.2%
Debt to equity ratio
₹8.19b
Debt
| Interest coverage ratio | 1.9x |
| Cash | ₹417.30m |
| Equity | ₹10.89b |
| Total liabilities | ₹13.01b |
| Total assets | ₹23.90b |
Recent financial health updates
Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?
Jan 26
Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly
May 21Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly
Jun 10Is Indoco Remedies (NSE:INDOCO) A Risky Investment?
Dec 27
Recent updates
Indoco Remedies Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected
Oct 27Earnings Troubles May Signal Larger Issues for Indoco Remedies (NSE:INDOCO) Shareholders
May 24Earnings Miss: Indoco Remedies Limited Missed EPS By 56% And Analysts Are Revising Their Forecasts
Jan 26Does Indoco Remedies (NSE:INDOCO) Have A Healthy Balance Sheet?
Jan 26We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Indoco Remedies Limited's (NSE:INDOCO) CEO For Now
Sep 16Here's Why Indoco Remedies (NSE:INDOCO) Can Manage Its Debt Responsibly
May 21Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Aug 31Indoco Remedies (NSE:INDOCO) Has Announced That It Will Be Increasing Its Dividend To ₹1.50
Jul 04Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Jul 02Indoco Remedies (NSE:INDOCO) Seems To Use Debt Quite Sensibly
Jun 10Does Indoco Remedies (NSE:INDOCO) Deserve A Spot On Your Watchlist?
Mar 25Indoco Remedies Limited's (NSE:INDOCO) Intrinsic Value Is Potentially 21% Below Its Share Price
Mar 09What Percentage Of Indoco Remedies Limited (NSE:INDOCO) Shares Do Insiders Own?
Feb 22Did You Miss Indoco Remedies' (NSE:INDOCO) 37% Share Price Gain?
Feb 07Indoco Remedies Limited's (NSE:INDOCO) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 17Is Indoco Remedies (NSE:INDOCO) A Risky Investment?
Dec 27Calculating The Intrinsic Value Of Indoco Remedies Limited (NSE:INDOCO)
Dec 06What Type Of Shareholders Own The Most Number of Indoco Remedies Limited (NSE:INDOCO) Shares?
Nov 14Financial Position Analysis
Short Term Liabilities: INDOCO's short term assets (₹10.3B) exceed its short term liabilities (₹8.0B).
Long Term Liabilities: INDOCO's short term assets (₹10.3B) exceed its long term liabilities (₹5.0B).
Debt to Equity History and Analysis
Debt Level: INDOCO's net debt to equity ratio (71.4%) is considered high.
Reducing Debt: INDOCO's debt to equity ratio has increased from 32.1% to 75.2% over the past 5 years.
Debt Coverage: INDOCO's debt is well covered by operating cash flow (27.1%).
Interest Coverage: INDOCO's interest payments on its debt are not well covered by EBIT (1.9x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/28 21:14 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Indoco Remedies Limited is covered by 16 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Sriraam Rathi | Anand Rathi Shares and Stock Brokers Limited |
| Sarabjit Nangra | Angel Broking Private Limited |
| Srivathsan Ramachandran | Avendus Spark |